AcariaHealth Highlights National Biosimilars Education Efforts with Three Events
AcariaHealth (NYSE:CNC) completed three national educational events in October focused on the U.S. biosimilars landscape.
Collaborations with the National Association of Specialty Pharmacy, Reuters Events, and an AcariaHealth webinar delivered practical guidance on biosimilar adoption, patient access, and specialty pharmacy readiness. Sessions covered regulatory and market updates, communication tactics to reduce provider and patient hesitancy, substitution rules, payer dynamics, and workflow optimization. On‑demand recordings of all three programs are available.
AcariaHealth (NYSE:CNC) ha completato tre eventi educativi nazionali in ottobre, incentrati sul panorama dei biosimilari negli Stati Uniti.
In collaborazione con la National Association of Specialty Pharmacy, Reuters Events e un webinar di AcariaHealth, sono state fornite linee guida pratiche su adozione dei biosimilari, accesso dei pazienti e prontezza della farmacia specializzata. Le sessioni hanno trattato aggiornamenti normativi e di mercato, tattiche di comunicazione per ridurre l’hesitancy di fornitori e pazienti, regole di sostituzione, dinamiche dei pagatori e ottimizzazione dei flussi di lavoro. Le registrazioni on-demand di tutti e tre i programmi sono disponibili.
AcariaHealth (NYSE:CNC) completó tres eventos educativos nacionales en octubre centrados en el panorama de biosimilares en Estados Unidos.
En colaboración con la National Association of Specialty Pharmacy, Reuters Events y un seminario web de AcariaHealth, se brindó orientación práctica sobre adopción de biosimilares, acceso de los pacientes y preparación de la farmacia especializada. Las sesiones abordaron actualizaciones regulatorias y de mercado, tácticas de comunicación para reducir la reticencia de proveedores y pacientes, reglas de sustitución, dinámicas de pagadores y optimización del flujo de trabajo. Las grabaciones a demanda de los tres programas están disponibles.
AcariaHealth (NYSE:CNC)가 미국 내 바이오시밀러 현황에 초점을 맞춘 10월의 전국 교육 행사 3회를 마쳤습니다.
National Association of Specialty Pharmacy, Reuters Events, 그리고 AcariaHealth의 웨비나와의 협력을 통해 바이오시밀러 도입, 환자 접근성, 전문 약국 준비성에 대한 실용적인 지침이 제시되었습니다. 세션은 규제 및 시장 업데이트, 공급자와 환자의 주저함을 줄이기 위한 소통 전략, 대체 규칙, 지불자 동향 및 워크플로우 최적화에 대해 다루었습니다. 세 프로그램의 주문형(on-demand) 녹화본이 모두 이용 가능합니다.
AcariaHealth (NYSE:CNC) a mené à bien trois événements éducatifs nationaux en octobre axés sur le paysage des biosimilaires aux États-Unis.
En collaboration avec la National Association of Specialty Pharmacy, Reuters Events et un webinaire d'AcariaHealth, des conseils pratiques sur l’adoption des biosimilaires, l’accès des patients et la préparation des pharmacies spécialisées ont été fournis. Les sessions ont couvert des mises à jour réglementaires et de marché, des tactiques de communication pour réduire l’hésitation des prestataires et des patients, les règles de substitution, les dynamiques des payeurs et l’optimisation des flux de travail. Les enregistrements à la demande des trois programmes sont disponibles.
AcariaHealth (NYSE:CNC) hat im Oktober drei nationale Bildungsveranstaltungen abgeschlossen, die sich demUS-Biosimilars-Landschaft widmeten.
In Zusammenarbeit mit der National Association of Specialty Pharmacy, Reuters Events und einem AcariaHealth-Webinar wurde praxisnahe Orientierung zu Biosimilar-Adoption, Patientenzugang und Bereitschaft der Spezialapotheken gegeben. Die Sitzungen behandelten regulatorische und Marktentwicklungen, Kommunikationstaktiken zur Verringerung der Zurückhaltung von Anbietern und Patienten, Substitutionsregeln, Kostenträger-Dynamiken und Optimierung von Arbeitsabläufen. Die On-Demand-Aufzeichnungen aller drei Programme stehen zur Verfügung.
أكرياهيلث (بورصة نيويورك: CNC) أنهت ثلاث فعاليات تعليمية وطنية في أكتوبر تركزت على مشهد البايوسيميلرز في الولايات المتحدة.
بالتعاون مع الجمعية الوطنية للصيدلة المتخصصة، وفعاليات رويترز، وبندر AcariaHealth، تم تقديم إرشادات عملية حول تبني البايوسيميلرز، وصول المرضى، واستعداد الصيدليات المتخصصة. تناولت الجلسات تحديثات تنظيمية وسوقية، وتكتيكات التواصل لتقليل تردد مقدمي الرعاية والمرضى، وقواعد الاستبدال، والديناميكيات الدافعة للدافعين وتخطيط سير العمل. تتوفر تسجيلات الطلب عند الطلب لجميع البرامج الثلاثة.
- None.
- None.
Sessions with AcariaHealth, the National Association of Specialty Pharmacy (NASP), and Reuters Events deliver actionable insights on biosimilar adoption, patient access, and specialty pharmacy readiness
"AcariaHealth is committed to equipping healthcare professionals with the knowledge and tools needed to confidently integrate biosimilars into patient care," said Jessica Ciccolella-Kahl, CEO of AcariaHealth. "Education is essential to improving access and ensuring patients benefit from safe, effective, and affordable therapies."
NASP Lunch & Learn: "Biosimilars Unveiled: Strategies for Success in Specialty Pharmacy"
Speaker: Kathleen Stenberg, PharmD, CSP, Lead Specialty Pharmacist, AcariaHealth
This session delivered foundational biosimilar education, addressed common questions from providers and patients, and outlined strategies for overcoming substitution and workflow challenges within specialty pharmacy.
Watch the recording: NASP Lunch & Learn Replay
Reuters Events Panel: "Biosimilars in
Panelist: Kathleen Stenberg, PharmD, CSP, Lead Specialty Pharmacist, AcariaHealth
Industry leaders shared perspectives on biosimilar adoption trends, policy considerations, and access challenges. Dr. Stenberg offered specialty-pharmacy insights focused on patient care, payer expectations, and operational readiness for biosimilars.
Watch the recording: Reuters Events Replay
AcariaHealth Webinar: "Biosimilars in Practice: Maintaining Access and Prioritizing Patient Care"
Speakers:
- Alysha Robinson, PharmD, CSP — Director, Specialty Pharmacy Program Management
- Kathleen Stenberg, PharmD, CSP — Lead Specialty Pharmacist
- Robin Waida — Director, Physician Sales
The AcariaHealth-hosted webinar covered biosimilar fundamentals, addressed common misconceptions, and explored both patient and provider hesitancy. Presenters also shared actionable strategies for supporting successful biosimilar integration across care settings.
Watch the recording: AcariaHealth Webinar Replay
Key Insights Across All Sessions
- Current regulatory and market updates shaping biosimilar adoption
- Communication approaches to reduce provider and patient hesitancy
- System-level considerations, including substitution rules, payer dynamics, and workflow optimization
About AcariaHealth
AcariaHealth is a national specialty pharmacy dedicated to supporting patients with complex conditions through personalized care and clinical expertise. As a Centene company, AcariaHealth leverages the strength of the largest Medicaid managed care organization to deliver transformative outcomes across the country.
Learn more: AcariaHealth.com
Follow us on LinkedIn
View original content to download multimedia:https://www.prnewswire.com/news-releases/acariahealth-highlights-national-biosimilars-education-efforts-with-three-events-302622247.html
SOURCE AcariaHealth
FAQ
What did AcariaHealth announce about biosimilars on November 20, 2025 (CNC)?
Which organizations partnered with AcariaHealth for the biosimilars events (CNC)?
What topics did the AcariaHealth (CNC) sessions cover for specialty pharmacy?
Who represented AcariaHealth on the Reuters Events panel about biosimilars (CNC)?
How can healthcare professionals access the AcariaHealth biosimilars recordings (CNC)?
What practical benefits did AcariaHealth say the events provide to clinicians (CNC)?
